Sergio Lupo

1.7k total citations
23 papers, 481 citations indexed

About

Sergio Lupo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Sergio Lupo has authored 23 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Sergio Lupo's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Sergio Lupo is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Sergio Lupo collaborates with scholars based in Argentina, United States and Italy. Sergio Lupo's co-authors include Kiat Ruxrungtham, Javier O Morales-Ramirez, Simon Vanveggel, Anton Pozniak, Beatriz Grinsztejn, L Rimsky, Dewald Steyn, Elly Katabira, Katia Boven and Andrés Binolfi and has published in prestigious journals such as PLoS ONE, Hepatology and AIDS.

In The Last Decade

Sergio Lupo

21 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Lupo Argentina 9 336 258 90 83 77 23 481
J Mira Spain 14 157 0.5× 42 0.2× 42 0.5× 21 0.3× 212 2.8× 26 404
Michael Maguire United Kingdom 10 271 0.8× 258 1.0× 26 0.3× 6 0.1× 82 1.1× 15 674
Paolo Troia-Cancio United States 9 179 0.5× 180 0.7× 127 1.4× 113 1.4× 65 0.8× 10 384
Anne Waldner France 9 233 0.7× 99 0.4× 97 1.1× 6 0.1× 192 2.5× 11 419
Darma Imran Indonesia 10 159 0.5× 125 0.5× 61 0.7× 2 0.0× 132 1.7× 38 396
Andrea Mastrángelo Italy 10 170 0.5× 100 0.4× 40 0.4× 2 0.0× 78 1.0× 21 380
C. Aquilina France 9 71 0.2× 53 0.2× 84 0.9× 11 0.1× 51 0.7× 21 259
Paul B. Tabereaux United States 14 56 0.2× 27 0.1× 105 1.2× 6 0.1× 55 0.7× 27 538
Luís A. B. Cruz Brazil 8 153 0.5× 99 0.4× 88 1.0× 3 0.0× 39 0.5× 12 301
Jovan Ranin Serbia 12 196 0.6× 124 0.5× 59 0.7× 166 2.2× 49 469

Countries citing papers authored by Sergio Lupo

Since Specialization
Citations

This map shows the geographic impact of Sergio Lupo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Lupo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Lupo more than expected).

Fields of papers citing papers by Sergio Lupo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Lupo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Lupo. The network helps show where Sergio Lupo may publish in the future.

Co-authorship network of co-authors of Sergio Lupo

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Lupo. A scholar is included among the top collaborators of Sergio Lupo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Lupo. Sergio Lupo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sued, Omar, Diego Cecchini, María José Rolón, et al.. (2022). A small cluster randomised clinical trial to improve health outcomes among Argentine patients disengaged from HIV care. The Lancet Regional Health - Americas. 13. 100307–100307. 2 indexed citations
2.
Gagliardi, Irene, et al.. (2022). Investigation of COVID-19 infection in subjects with Klinefelter syndrome. Journal of Endocrinological Investigation. 45(5). 1065–1069. 1 indexed citations
3.
Gagliardi, Irene, Stefania Bigoni, Sergio Lupo, et al.. (2022). Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who?. Journal of Community Genetics. 13(3). 271–280. 5 indexed citations
4.
5.
Lupo, Sergio, et al.. (2018). Assessing endocrine and immune parameters in human immunodeficiency virus-infected patients before and after the immune reconstitution inflammatory syndrome. Archives of Endocrinology and Metabolism. 62(1). 64–71. 5 indexed citations
6.
McComsey, Grace A., Sergio Lupo, Lesley Kahl, et al.. (2017). Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health. AIDS. 32(4). 477–485. 43 indexed citations
7.
8.
Bulacio, Lucía, et al.. (2013). Onicomicosis en pacientes con VIH. 19(1). 34–38.
9.
Marconi, Lorenzo, et al.. (2012). Hepatotoxicity of antiretrovirals in patients with human immunodeficiency virus and viral hepatitis coinfections. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
10.
Kozal, Michael J., Sergio Lupo, Edwin DeJesus, et al.. (2012). A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results. HIV Clinical Trials. 13(3). 119–130. 70 indexed citations
11.
Wilkin, Aimee, Anton Pozniak, Javier O Morales-Ramirez, et al.. (2011). Long-Term Efficacy, Safety, and Tolerability of Rilpivirine (RPV, TMC278) in HIV Type 1-Infected Antiretroviral-Naive Patients: Week 192 Results from a Phase IIb Randomized Trial. AIDS Research and Human Retroviruses. 28(5). 437–446. 45 indexed citations
12.
Cahn, Pedro, Julio Montaner, Patricia Patterson, et al.. (2011). Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen. PLoS ONE. 6(8). e23726–e23726. 16 indexed citations
13.
Pozniak, Anton, Javier O Morales-Ramirez, Elly Katabira, et al.. (2009). Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial. AIDS. 24(1). 55–65. 89 indexed citations
14.
Luque, Alicia G., et al.. (2008). Oral yeast carriage in HIV‐infected and non‐infected populations in Rosario, Argentina. Mycoses. 52(1). 53–59. 44 indexed citations
15.
16.
Luigi, Luigi Di, Marco Cappa, M D’Armiento, et al.. (2007). Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases. Medicina dello Sport. 60(3). 225–227. 2 indexed citations
17.
Angelis, Maria Vittoria De, Antonio Di Muzio, Sergio Lupo, et al.. (2001). Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier. Journal of Neuroimmunology. 121(1-2). 79–82. 24 indexed citations
18.
Lupo, Sergio, et al.. (2000). [Fever of unknown origin in patients infected with the human immunodeficiency virus (HIV)].. PubMed. 60(5 Pt 1). 623–30. 2 indexed citations
19.
Billat, Véronique, Marcello Faina, F Sardella, et al.. (1996). A comparison of time to exhaustion at [vdot]O2;max in elite cyclists, kayak paddlers, swimmers and runners. Ergonomics. 39(2). 267–277. 70 indexed citations
20.
Faina, Marcello, et al.. (1982). Cardiotelemetric and blood lactate investigations in paraplegic subjects during several sports activities.. PubMed. 22(2). 172–84. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Mira Breakdown of academic impact, for papers by Michael Maguire Breakdown of academic impact, for papers by Paolo Troia-Cancio Breakdown of academic impact, for papers by Anne Waldner Breakdown of academic impact, for papers by Darma Imran Breakdown of academic impact, for papers by Andrea Mastrángelo Breakdown of academic impact, for papers by C. Aquilina Breakdown of academic impact, for papers by Paul B. Tabereaux Breakdown of academic impact, for papers by Luís A. B. Cruz Breakdown of academic impact, for papers by Jovan Ranin
Rankless by CCL
2026